Form 8-K - Current report:
SEC Accession No. 0000950170-22-011821
Filing Date
2022-06-17
Accepted
2022-06-17 17:00:52
Documents
12
Period of Report
2022-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20220615.htm   iXBRL 8-K 62548
  Complete submission text file 0000950170-22-011821.txt   183574

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20220615_pre.xml EX-101.PRE 10287
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20220615.xsd EX-101.SCH 2469
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20220615_lab.xml EX-101.LAB 14010
6 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20220615_htm.xml XML 4928
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 221024784
SIC: 2834 Pharmaceutical Preparations